On December 27, 2023, Ruibo (Hangzhou) Pharmaceutical Technology Co., Ltd. closed the transaction. The company has completed the industrial and commercial change registration and obtained a new Business License issued by the Hangzhou Qiantang District Market Supervision Administration.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.12 CNY | +0.06% | +3.33% | -33.42% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.42% | 2B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 50 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd